Monday, March 21, 2016 | |||
9:00 am - 10:15 am | Plenary Session 1: Opening Ceremony Chair: Jean-Pierre Armand, Cancer Institute Gustave Roussy Chair: Giuseppe Giaccone, Georgetown University | ||
10:40 am - 12:00 pm | Plenary Session 2: Immuno-oncology (1) Chair: Michael Atkins, Geogetown-Lombardi Comprehensive Cancer Center Chair: Gail Eckhardt, University of Colorado Cancer Center | ||
1:00 pm - 2:30 pm | Plenary Session 3: Phase 1 Studies - Completed or in Progress (miscellaneous drugs & targets) Chair: Lesley Seymour, Queen's University Chair: Shivaani Kummar, Stanford University Cancer Institute | ||
2:55 pm - 4:35 pm | Plenary Session 4: New Drugs and Targets in Hemato-Oncology Chair: Yves Pommier, National Cancer Institute Chair: Filippo de Braud, Fondazione IRCCS Istituto Nazionale dei Tumori | ||
4:45 pm - 5:45 pm | Special Symposium (non-CME) Immuno-Oncology and Third-Generation Tyrosine Kinase Inhibitors Company Updates Chair: Hilary Calvert, UCL Cancer Institute Chair: Jean-Pierre Armand, Cancer Institute Gustave Roussy | ||
6:00 pm - 7:00 pm | Poster Viewing & Welcome Reception | ||
Tuesday, March 22, 2016 | |||
8:50 am - 10:20 am | Plenary Session 5: Immuno-oncology (2) Chair: Antoine Italiano, Institut Bergonié Chair: Filip Janku, MD Anderson Cancer Center | ||
10:45 am - 12:15 pm | Plenary Session 6: Targeting Difficult Targets Chair: Geoffrey Shapiro, Dana-Farber Cancer Institute Chair: Donald Bottaro, National Cancer Institute | ||
12:15 pm - 1:15 pm | Meet-the-professor session: How to give a talk and how to write a paper Lee Ellis, MD Anderson Cancer Center | ||
1:15 pm - 2:55 pm | Plenary Session 7: Cell Cycle and DNA Targets Chair: Michael Pishvaian, Georgetown University Chair: Hilary Calvert, UCL Cancer Institute | ||
3:20 pm - 5:00 pm | Plenary Session 8: Drug penetration into the Central Nervous System Chair: Susan Bates, Columbia University Medical Center Chair: Antoine Italiano, Institut Bergonié | ||
Wednesday, March 23, 2016 | |||
8:30 am - 9:45 am | Plenary Session 9: Drug Development Methodology Chair: Jean-Charles Soria, Cancer Institute Gustave Roussy Chair: Lee Ellis, MD Anderson Cancer Center | ||
10:15 am - 12:15 pm | Plenary Session 10: Miscellaneous Drugs and Targets (1) Chair: Anthony Tolcher, South Texas Accelerated Research Therapeutics Chair: Keith Flaherty, Massachusetts General Hospital | ||
1:00 pm - 3:00 pm | Plenary Session 11: Miscellaneous Drugs and Targets (2) Chair: Udai Banerji, The Institute of Cancer Research Chair: Arne Östman, Karolinska Institutet | ||
3:05 pm - 3:10 pm | Closing remarks Giuseppe Giaccone, Georgetown University |